Peter J. Barnes

Peter J. Barnes serves as Professor of Thoracic Medicine and Head of Respiratory Medicine at Imperial College London's Faculty of Medicine, National Heart and Lung Institute, and holds an Honorary Consultant Physician position at Royal Brompton Hospital, London. Recognized as Europe's most highly cited clinical scientist and the world's most highly cited respiratory researcher over the past two decades, his work has profoundly impacted respiratory medicine.

His research centers on unraveling cellular and molecular mechanisms of asthma and COPD, with emphasis on therapeutic development and biomarker discovery through multidisciplinary translational approaches that bridge fundamental science with clinical applications. This integrative methodology provides novel insights into airway disease pathogenesis and treatment.

Key scientific honors include:

• Elected Fellow of the Royal Society (2007)
• Honorary Doctorate from University of Ferrara, Italy
• Honorary Doctorate from University of Athens, Greece
• Honorary Doctorate from University of Tampere, Finland
• Honorary Doctorate from University of Leuven, Belgium
• Honorary Doctorate from University of Maastricht, Netherlands

Professor Barnes actively shapes global respiratory care as a current member of WHO/NIH scientific committees for asthma (GINA) and COPD (GOLD) guidelines. His entrepreneurial efforts include co-founding RespiVert, an Imperial spin-out acquired by Johnson & Johnson that developed novel inhaled therapies for severe respiratory conditions.